Inflammatory and stress-related protein (None)

Inflammatory and stress-related protein is a collective term for a diverse group of molecules that mediate cellular and systemic responses to stressors such as infection, injury, and environmental changes (StatPearls, 2023). This group encompasses cytokines like Tumor Necrosis Factor (TNF) and Interleukin-6 (IL-6), which drive the inflammatory cascade, as well as molecular chaperones like Heat Shock Proteins (HSPs) that ensure proteostasis during thermal or oxidative stress (NCBI, 2022). These proteins are essential for survival, coordinating immune cell recruitment and cellular repair (UniProt, 2024). However, their chronic or excessive activation is a primary driver of diseases such as rheumatoid arthritis, atherosclerosis, and neurodegeneration (PubMed, 2021). Because this is a broad category rather than a single target, therapeutic intervention focuses on specific components, such as using monoclonal antibodies to neutralize cytokines or small molecules to inhibit stress-activated kinases (NIH, 2023). Targeting these pathways requires careful balance, as systemic inhibition can lead to significant safety concerns, including increased infection risk and impaired physiological stress responses (StatPearls, 2023). Overall, these proteins represent a critical interface between environmental stimuli and the host's pathological or adaptive responses.

Other names

Acute phase proteinStress proteinInflammatory mediatorCytokine and chaperone

The mechanisms of action are diverse and specific to the individual protein targeted; they include the neutralization of pro-inflammatory cytokines, competitive inhibition of cyclooxygenase enzymes, and modulation of heat shock protein activity to prevent protein aggregation (NIH, 2023; PubMed, 2021).